| Bladder Neoplasm investigated in trials for …INVESTIGATED_IN_TRIALSderived147 of 147show fewer |
|---|
| → investigated in trials for | Gemcitabinesmall molecule 142 trials (45 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 142 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 109 trials (34 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 109 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal_antibody 76 trials (43 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 76 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mitomycinsmall molecule 41 trials (18 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 41 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall_molecule 41 trials (5 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 41 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 37 trials (10 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 37 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal_antibody 36 trials (16 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 36 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 31 trials (16 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 31 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enfortumab Vedotinadc 30 trials (24 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 30 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall molecule 28 trials (10 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 28 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 26 trials (12 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 23 trials (2 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fluorouracilsmall molecule 19 trials (11 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Methotrexatesmall molecule 19 trials (3 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinblastinesmall_molecule 18 trials (3 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avelumabmonoclonal antibody 17 trials (7 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Filgrastimother 14 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sunitinibsmall molecule 13 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tremelimumabmonoclonal_antibody 10 trials (4 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabozantinibsmall molecule 9 trials (6 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumabmonoclonal antibody 8 trials (2 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinfluninesmall_molecule 8 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bacillus Calmette-Guerin BCG 7 trials (3 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 7 trials (4 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erdafitinibsmall_molecule 7 trials (4 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sacituzumab Govitecanadc 7 trials (4 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Toripalimabmonoclonal_antibody 7 trials (5 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Epirubicinsmall molecule 6 trials (3 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tislelizumabmonoclonal_antibody 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cemiplimabmonoclonal antibody 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Disitamab Vedotinadc 5 trials (5 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ifosfamidesmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 5 trials (5 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lapatinibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nadofaragene Firadenovecgene therapy 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegfilgrastimother 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemetrexedsmall_molecule 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Eribulinsmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinib Hydrochloridesmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gefitinibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nab-paclitaxel 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Olaparibsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pazopanibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sirolimussmall_molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Valrubicinsmall_molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aldesleukinother 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Celecoxibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall molecule 3 trials (3 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Metforminsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pertuzumabmonoclonal antibody 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Romidepsinother 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenib Tosylatesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tisotumab Vedotinadc 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumab Emtansineadc 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afatinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bortezomibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capecitabinesmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Catumaxomabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cetuximabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Crizotinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Datopotamab Deruxtecanadc 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Degarelixother 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dexamethasonesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enzalutamidesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Infigratinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenalidomidesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Palbociclibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sapanisertibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tamoxifensmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temsirolimussmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tipifarnibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vandetanibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vismodegibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vorinostatsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | 5-Fluoro-2-Deoxycytidine 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abemaciclibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adavosertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adebrelimabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adjuvant Chemotherapy 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afliberceptother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alectinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alisertibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Amrubicinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aspirinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belinostatsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Berzosertibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bicalutamidesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Binimetinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bosutinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Brentuximab Vedotinadc 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabazitaxelsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Camizestrantsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Camrelizumabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capivasertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cobimetinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Copanlisibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dabrafenibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Daratumumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dasatinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Decitabinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Denosumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dovitinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumab/Tremelimumab Regimen 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fexagratinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fulvestrantsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Futibatinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imiquimodsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Immunotherapy 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipatasertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumab/Nivolumab Regimen 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Larotrectinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenvatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lonafarnibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Neratinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Niraparibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nogapendekin Alfa Inbakiceptother 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Osimertinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panitumumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemigatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Picoplatinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Porfimer 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pralatrexatesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ramucirumabmonoclonal_antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Retifanlimabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rogaratinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rucaparibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Seribantumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tanespimycinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tarlatamabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Taselisibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tazemetostatsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tovorafenibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trametinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumab Deruxtecanadc 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Valproic Acidsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Veliparibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vemurafenibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinorelbinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |